Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted)

Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted)

Detaylı Bibliyografya
Asıl Yazarlar:	Hillmen, P, Pettitt, A, Schuh, A, Milligan, D, Bowles, K, Bareford, D, Riaz, J, Follows, G, Rule, S, Wallis, J, Gribben, J, Noble, R, Pocock, C, Lisby, S, Carey, J, Gupta, I, Chang, C, McKeown, A
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	2014

Benzer Materyaller

Azathioprine, cyclophosphamide and chlorambucil.
Yazar:: Luqmani, R, ve diğerleri
Baskı/Yayın Bilgisi: (1990)

UK experience of Ofatumumab in refractory B-CLL
Yazar:: Varghese, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Chlorambucil-Induced Acute Interstitial Pneumonitis
Yazar:: Hammad Shafqat, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Rapid desensitization for chlorambucil drug fever
Yazar:: E Weber, ve diğerleri
Baskı/Yayın Bilgisi: (2007-07-01)

Ofatumumab retreatment and maintenance in patients with fludarabine-refractory CLL.
Yazar:: Osterborg, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

UK Medical Research Council CLL3 - A randomized trial of the addition of epirubicin to standard chlorambucil treatment.
Yazar:: Catovsky, D, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

The Occurrence of Richter’s Syndrome during Treatment with Obinutuzumab and Chlorambucil
Yazar:: Teng Fong Ng, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents
Yazar:: Sijongesonke Peter, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Long-term management of a cat with nasopharyngeal lymphoma by chlorambucil
Yazar:: Kaho Takahashi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Chlorambucil combination therapy in refractory serpiginous choroiditis: A cure?
Yazar:: Arash Maleki, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Synthesis, Characterization, and Cytotoxicity Evaluation of Chlorambucil-Functionalized Mesoporous Silica Nanoparticles
Yazar:: Juliana Camila Fischer Karnopp, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Chlorambucil-Loaded Graphene-Oxide-Based Nano-Vesicles for Cancer Therapy
Yazar:: Surabhi Kumari, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
Yazar:: Tacconi, E, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Combination of Chlorambucil and Mercaptopurine Show Effective Anti-Cancer Effects in Mice Model
Yazar:: Xu W, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Nasal Lymphoma with Low Mitotic Index in Three Cats Treated with Chlorambucil and Prednisolone
Yazar:: Karen W. L. Ng, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Yazar:: Othman Al-Sawaf, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Growth arrest of BCR-ABL positive cells with a sequence-specific polyamide-chlorambucil conjugate.
Yazar:: C James Chou, ve diğerleri
Baskı/Yayın Bilgisi: (2008-01-01)

In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs.
Yazar:: Michael J Reese, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Chlorambucil-iron oxide nanoparticles as a drug delivery system for leukemia cancer cells
Yazar:: Al-Ali, Samer Hasan Hussein, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Retrospective Safety Evaluation of Combined Chlorambucil and Toceranib for the Treatment of Different Solid Tumours in Dogs
Yazar:: Yuk-Yin Lai, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Kolaviron and L-Ascorbic Acid Attenuate Chlorambucil-Induced Testicular Oxidative Stress in Rats
Yazar:: Ebenezer Tunde Olayinka, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
Yazar:: Eliana MC Tacconi, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Lenalidomide can be safely combined with chlorambucil and rituximab in older patients with chronic lymphocytic leukemia
Yazar:: Candida Vitale, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Nanocarrier systems loaded with IR780, iron oxide nanoparticles and chlorambucil for cancer theragnostics
Yazar:: Phuong-Thao Dang-Luong, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Successful rescue treatment using chlorambucil for presumed recurrence of sinonasal lymphoma in a cat
Yazar:: Sho Goto, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Discovery of a potent olaparib–chlorambucil hybrid inhibitor of PARP1 for the treatment of cancer
Yazar:: Hongyu Qin, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Biochemical and pathological studies on the effects of levamisole and chlorambucil on Ehrlich ascites carcinoma-bearing mice
Yazar:: Fakhry S. Salem, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

In vivo antitumor activity study of targeted chlorambucil-loaded nanolipid carrier for breast cancer
Yazar:: Ameer S. Sahib, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Chlorambucil-Iron Oxide Nanoparticles as a Drug Delivery System for Leukemia Cancer Cells
Yazar:: Hussein-Al-Ali SH, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
Yazar:: Casado LF, ve diğerleri
Baskı/Yayın Bilgisi: (2016-09-01)

Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study
Yazar:: Andrea Visentin, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Chlorambucil and fludarabine as a new pre-transplant conditioning for patients with chronic lymphocytic leukemia: results of in vivo experiments
Yazar:: J. Tomenendalova, ve diğerleri
Baskı/Yayın Bilgisi: (2008-10-01)

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Yazar:: Othman Al-Sawaf, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Fluorometric and Docking Analysis of the Complex Formation between an Anti-Cancer Drug, Chlorambucil and Bovine Serum Albumin
Yazar:: Saufi, Aimi Nabila Mohamad, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Chlorambucil effect on B lymphocites in the peripheral blood of patients with chronic lymphocytic leukemia: Cell ultrastructure investigation
Yazar:: Brajušković Goran R., ve diğerleri
Baskı/Yayın Bilgisi: (2003-01-01)

Chlorambucil Conjugated Ugi Dendrimers with PAMAM-NH<sub>2</sub> Core and Evaluation of Their Anticancer Activity
Yazar:: Nalin Seixas, ve diğerleri
Baskı/Yayın Bilgisi: (2019-02-01)

The interaction of the chemotherapeutic drug chlorambucil with human glutathione transferase A1-1: kinetic and structural analysis.
Yazar:: Michael Karpusas, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORAMBUCIL IN TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: 5-YEAR FOLLOW-UP OF ELEVATE-TN
Yazar:: J. P. Sharman, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study
Yazar:: Anne-Sophie Michallet, ve diğerleri
Baskı/Yayın Bilgisi: (2018-04-01)

pH-triggered dynamic erosive small molecule chlorambucil nano-prodrugs mediate robust oral chemotherapy
Yazar:: Xin Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)